| Incyte Corp | 69,29 / -0,70% |
| Data / Laikas | 24.09. / 17:35 |
| Pok. / Pok.(%) | -0,49 / -0,70% |
| Bid | 69,25 / 1 |
| Ask | 69,35 / 1 |
| Atidaryti | 69,47 |
| Ankstesnį uždaryti | 69,78 |
| Aukšč. | 70,09 |
| Žem. | 68,96 |
| APYVARTA [USD] | 750.189,64 |
| APYVARTA [Units] | 17.525 |
| Price fixings | 103 |
| ISIN | US45337C1027 |
| Simbolis | INCY |
| Birža | Cboe US |
| Rūšis | Stock |
Visos biržos
| Birža | Paskutinis | APYVARTA | |
|---|---|---|---|
| NASDAQ | 69,3600 |  |
392.272 |
| Cboe US | 69,29 | |
17.525 |
| IEX | 69,20 | |
10.823 |
| Moscow | 5.055,00 | |
757 |
| TradeGate | 59,500 | |
728 |
| London Domes.. | 69,60 | |
267 |
| München | 59,40 |  |
120 |
| gettex | 59,220 | |
109 |
| Frankfurt | 59,2000 | |
100 |
| Düsseldorf | 59,16 | |
0 |
| Berlin | 59,46 | |
0 |
| Lang & Schwa.. | 59,20 | |
|
| Stuttgart | 59,280 | |
|
| Quotrix | 59,4600 | |
|
| Mexico | 1.560,00 |  |
8 |
Naujienos
- MacroGenics Announces Clinical Results from Cohort A Part 1 of Phase 2/3 MAHOGANY Study of Margetuximab in Combination with Retifanlimab in Gastroesophageal Adenocarcinoma at ESMO 2021
16.09.2021 / 08:45 - GlobeNewswire - Brickell Biotech Expands Leadership Team, Appointing Dr. Monica Luchi as Chief Medical Officer
01.09.2021 / 13:05 - GlobeNewswire - Bolt Biotherapeutics and Innovent Biologics Announce Collaboration to Develop Three New Oncology Boltbody™ ISAC Programs
26.08.2021 / 22:05 - GlobeNewswire - BriaCell and ImaginAb Announce Collaboration to Evaluate Immunotherapy Imaging Technology in Advanced Breast Cancer
19.08.2021 / 14:00 - GlobeNewswire - SEC Charges Biopharmaceutical Company Employee with Insider Trading
17.08.2021 / 16:26 - Newsfile Corp